Innopharma Technology R&D

Innoskills is part of the Innopharma Group, a technology and education company focused on helping to make the people, processes and businesses within the Pharmaceutical and Medical Device industry ready for a smarter, technology driven future. 


Innopharma Technology are a team of engineers, software developers and scientists developing smart technologies and applications for the Pharma industry. They work at the forefront of Pharmaceutical process development, partnering with many of the world's Pharma household names to help them bring Advanced Manufacturing methodologies to their processes.

Driving the IoT technology revolution in Pharma

Innopharma Technology has joined the IoT revolution with a vision that involves fusing sensor data and process data with artificial intelligence and predictive analytics to accomplish advanced levels of optimisation efficiency and control. 

Innopharma Technology is driving this through the development of SmartX. This consists of a suite of modular technology and professional services for both Process Development and Manufacturing. It enables users to collect, contextualise and analyse process and PAT data and also to develop and implement full automated process control. 

This Smart Technology is highly valued within the pharmaceutical industry as it provides a competitive advantage in formulation development, technical transfer and production. Innopharma Technology continues to actively develop vertically integrated manufacturing intelligence solutions that utilise emerging technologies such as artificial intelligence and predictive analytics to improve drug quality and patient safety and meet the pharmaceutical manufacturing challenges of today. 

Our research efforts continue to result not only in some great technology but also in the growth of strong collaborative relationships with pharmaceutical, food and medtech companies, and also process equipment manufacturers and analytical technology partners.

All of this R&D at the cutting edge of the Pharmaceutical industry places Innopharma in a unique position of understanding the needs of industry and focusing R&D effort to respond with solutions that make the best use of emerging technologies


Smarter drug development 

Innopharma Labs were one of only two Irish companies to receive funding from the EU's Horizon 2020 programme in 2018, and one of 65 EU based companies to receive funding in the latest round.

Horizon 2020 is the biggest ever EU Research and Innovation programme, with nearly €80 billion of funding available over 7 years (2014 to 2020). The fund was established to encourage breakthrough discoveries and world-firsts, taking great ideas from the lab to the market.

The European Commission received 1,644 proposals from a broad range of sectors, and a proposal and competitive pitch process were used to select the final 65. The funding allows companies with new innovations to take a product idea from initial lab-based proof of concept and scale it for market launch through support for activities like demonstrations and testing, as well as through coaching and acceleration services.

Find out more about Innopharma Technology.


Winners of Irish Times Innovation of the Year 2018 

Innopharma Labs were the very proud recipients of the Innovation of the Year title. The award was given for our work on the development of a Smart platform for data-led process development in Pharmaceuticals. Our mission is to help the Pharmaceutical industry develop drugs in a faster, smarter and more data-driven way. Read more about our Innovation Award win. 

Irish Times Innovation of the Year Winner

© 2018 Innopharma. All rights reserved.

PrivacyTerms of UseHome